Medical Devices and Human Tissue Advisory Committee (MDHTAC)

Its primary role is to make recommendations to the Minister and advise the Department about the suitability of medical devices and human tissues products (products) for listing on the Prescribed List of Benefits for Medical Devices and Human Tissue Products (Prescribed List or PL) and their associated benefits, or on amending the details of the existing billing codes (for the products already listed on the PL), or on any other post-listing activities as required. The Prescribed List identifies the mimimum amount payable by private health insurers for medical devices and products.